The clinic also applied to patient assistance programs on behalf of patients, such as the program administered by the Boehringer Ingelheim Cares Foundation (29) that provides free sodium-glucose cotransporter-2 inhibitors to patients with type 2 diabetes, and the program administered by the US Department of Health and Human Services that provides free access to daily oral HIV pre-exposure prophylaxis medication for people at risk of acquiring HIV. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.